A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors
Background Recent studies have identified ribonucleotide reductase subunit M2 (RRM2) as a putative promoter of tumors. However, no systematic analysis of its carcinogenicity has been conducted. Methods The potential functions of RRM2 in various tumor types were investigated using data from the Genot...
Main Authors: | Yaqun Li, Wenhuan Fu, Zikai Geng, Yun Song, Xionggang Yang, Tianye He, Jian Wu, Bin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/14432.pdf |
Similar Items
-
Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
by: Zijian Zhou, et al.
Published: (2022-06-01) -
Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus
by: Bouchra Kitab, et al.
Published: (2023-01-01) -
A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors
by: Yang Liu, et al.
Published: (2024-01-01) -
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
by: Zanwen Zuo, et al.
Published: (2024-01-01) -
The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
by: Lang Cheng, et al.
Published: (2023-01-01)